Delivery Order SPE2DB22D2007-SPE2DB24FJ4RG

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has a ceiling value of $55,204.20 and an ultimate completion date of September 24, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $17,940.63 and a period of performance through May 27, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,920.84 and runs through April 25, 2025. It is a firm fixed-price contract for the supply of DARZALEX FASPRO, a specialty medication used in the treatment of various medical conditions. The contract is not set aside for any specific business category. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $59,802.10 firm-fixed-price contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,920.84, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 25, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the federal government. The contract is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,920.84 and is for the delivery of DARZALEX FASPRO, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This contract does not have a set-aside designation, indicating it was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The firm-fixed-price contract has a ceiling value of $5,980.21 and a period of performance ending on June 3, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The total ceiling value of the contract is $5,980.21, with a period of performance extending to July 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4RG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The contract is a firm-fixed price agreement with a ceiling value of $44,163.36 and an ultimate completion date of August 20, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical products and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives.

Generated 10/29/24, 9:17 AM